Am­gen R&D chief Sean Harp­er hits the ex­its with a one-way tick­et to ear­ly-stage biotech

Sean Harp­er is join­ing the mi­gra­tion out of big bio­phar­ma and in­to the world of emerg­ing biotechs.

The head of R&D at Am­gen has turned in his no­tice, 6 years af­ter tak­ing the se­nior R&D po­si­tion va­cat­ed by Roger Perl­mut­ter.

We don’t know right now where he’s head­ed, but in a state­ment Am­gen said that the 55-year-old is leav­ing Am­gen and “plans to pur­sue op­por­tu­ni­ties in the ear­ly-stage biotech­nol­o­gy com­mu­ni­ty.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER